InvestorsHub Logo

Zenguy

11/14/18 7:59 PM

#2475 RE: Chenteddybear #2474

Ug! Anyone a subscriber? I would be interested in hearing from the CEO.
This has been a difficult week watching this tank every day 10-20%...
The only short term hope might be the listing to CSX......for more volume.....and now that seems late.......
I'm cancelling Christmas.....lol
Peace!

Farmer7

11/14/18 10:45 PM

#2476 RE: Chenteddybear #2474

Sounds like they have a lot of announcements coming. More partners, patent applications, and exciting programs to announce in 2019. Sounds like more announcements through the holidays. They seem to really be pushing their drug delivery system for patents and proving how NXEN drugs can deliver an instant fix, rather then a drug delivery system like GWP$ does. Their drug takes 3.5 months to take full effect, whereas NXEN takes full effect immediately for epilepsy. Our nerve gas drug we know about works the same way for comparison.

IAmTopG

11/15/18 12:41 AM

#2478 RE: Chenteddybear #2474

Mind sharing the info? :)

Jascom

11/15/18 8:06 AM

#2484 RE: Chenteddybear #2474

Thanks for that lead. Good interview. But I wouldn't characterize it as "analyst coverage". The Wall Street Reporter gets paid by the company for these presentations. Nevertheless it was a good interview with the CEO sounding experienced and competent.

High_Profits

11/15/18 12:32 PM

#2491 RE: Chenteddybear #2474

$NXEN New CEO Audio Interview

Nexien BioPharma, Inc (OTC: $NXEN) Developing a cannabinoid-based drug pipeline.:

http://www.wallstreetreporter.com/2018/11/nexien-biopharma-inc-otc-nxen-developing-a-cannabinoid-based-drug-pipeline/

https://nexienbiopharma.com/